EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Yin Yang 1‐Induced Long Noncoding RNA DUXAP9 Drives the Progression of Oral Squamous Cell Carcinoma by Blocking CDK1‐Mediated EZH2 Degradation

Wenkai Zhou, Yisheng Feng, Chengzhong Lin, Chi Kuan Chao, Ziqi He, Shiyao Zhao, Jieyuan Xue, Xu-Yun Zhao, Wei Cao iD

Advanced Science · 2023-09 · 10 (25)

DOI: 10.1002/advs.202207549 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 03.07.2023. Verfasst von Wenkai Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial & Head and Neck Oncology, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong Universit…. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, RNA, Long Noncoding, Mouth Neoplasms, Head and Neck Neoplasms. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Innovation research team of high-level local universities in Shanghai, Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

LncRNAs play a critical role in oral squamous cell carcinoma (OSCC) progression. However, the function and detailed molecular mechanism of most lncRNAs in OSCC are not fully understood. Here, a novel nuclear‐localized lncRNA, DUXAP9 (DUXAP9), that is highly expressed in OSCC is identified. A high level of DUXAP9 is positively associated with lymph node metastasis, poor pathological differentiation, advanced clinical stage, worse overall survival, and worse disease‐specific survival in OSCC patients. Overexpression of DUXAP9 significantly promotes OSCC cell proliferation, migration, invasion, and xenograft tumor growth and metastasis, and upregulates N‐cadherin, Vimentin, Ki67, PCNA, and EZH2 expression and downregulates E‐cadherin in vitro and in vivo, whereas knockdown of DUXAP9 remarkably suppresses OSCC cell proliferation, migration, invasion, and xenograft tumor growth in vitro and in vivo in an EZH2‐dependent manner. Yin Yang 1 (YY1) is found to activate the transcriptional expression of DUXAP9 in OSCC. Furthermore, DUXAP9 physically interacts with EZH2 and inhibits EZH2 degradation via the suppression of EZH2 phosphorylation, thereby blocking EZH2 translocation from the nucleus to the cytoplasm. Thus, DUXAP9 can serve as a promising target for OSCC therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellRNA, Long NoncodingMouth NeoplasmsHead and Neck NeoplasmsHumansSquamous Cell Carcinoma of Head and NeckYin-YangCell Line, TumorCell ProliferationEnhancer of Zeste Homolog 2 ProteinCDC2 Protein Kinase

Stichwörter der Autor:innen

EZH2LncRNA DUXAP9Yin Yang 1 (YY1)oral squamous cell carcinomaubiquitination

Substanzen

RNA, Long NoncodingEZH2 protein, humanEnhancer of Zeste Homolog 2 ProteinCDK1 protein, humanCDC2 Protein Kinase

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial & Head and Neck Oncology, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.
  • National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai, 200011, China.
  • The 2nd Dental Center, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, College of Stomatology, Shanghai Jiao Tong University, Shanghai, 200011, China.
  • Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, China.
  • Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Key Laboratory of Cell Differentiation and Apoptosis of the Chinese Ministry of Education, Shan…

ORCID-Profile: Wei Cao

Förderung

  • National Natural Science Foundation of China
  • Innovation research team of high-level local universities in Shanghai
  • Science and Technology Commission of Shanghai Municipality
  • Science and Technology Innovation Plan Of Shanghai Science and Technology Commission

Zitieren

APA

Zhou, W., Feng, Y., Lin, C., Chao, C. K., He, Z., Zhao, S., Xue, J., Zhao, X. Y., & Cao, W. (2023). Yin Yang 1‐Induced Long Noncoding RNA DUXAP9 Drives the Progression of Oral Squamous Cell Carcinoma by Blocking CDK1‐Mediated EZH2 Degradation. Advanced Science, 10(25). https://doi.org/10.1002/advs.202207549

Vancouver

Zhou W, Feng Y, Lin C, Chao CK, He Z, Zhao S, et al. Yin Yang 1‐Induced Long Noncoding RNA DUXAP9 Drives the Progression of Oral Squamous Cell Carcinoma by Blocking CDK1‐Mediated EZH2 Degradation. Advanced Science. 2023;10(25). doi:10.1002/advs.202207549

BibTeX
@article{Zhou2023,
  author = {Zhou, Wenkai and Feng, Yisheng and Lin, Chengzhong and Chao, Chi Kuan and He, Ziqi and Zhao, Shiyao and Xue, Jieyuan and Zhao, Xu-Yun and Cao, Wei},
  title = {Yin Yang 1‐Induced Long Noncoding RNA DUXAP9 Drives the Progression of Oral Squamous Cell Carcinoma by Blocking CDK1‐Mediated EZH2 Degradation},
  journal = {Advanced Science},
  year = {2023},
  volume = {10},
  number = {25},
  doi = {10.1002/advs.202207549}
}
Kostenlos starten →